These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26142356)

  • 1. Regulating Direct-to-Consumer Drug Information: A Case Study of Eli Lilly's Canadian 40over40 Erectile Dysfunction Campaign.
    Pipon JC; Williams-Jones B
    Healthc Policy; 2015 May; 10(4):16-23. PubMed ID: 26142356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Familiarization and Therapeutic Misconception Via Direct-to-Consumer Information.
    Bélisle-Pipon JC; Williams-Jones B
    J Bioeth Inq; 2015 Jun; 12(2):259-67. PubMed ID: 25963773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2019 Oct; 44(5):765-787. PubMed ID: 31199865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction.
    Waack KE; Ernst ME; Graber MA
    Ann Pharmacother; 2004 Dec; 38(12):2029-34. PubMed ID: 15507499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a direct-to-consumer information campaign on prescription patterns for overactive bladder.
    Zaitsu M; Yoo BK; Tomio J; Nakamura F; Toyokawa S; Kobayashi Y
    BMC Health Serv Res; 2018 May; 18(1):325. PubMed ID: 29724205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can direct-to-consumer advertising of prescription drugs be effectively regulated?
    Lexchin J; Menkes DB
    N Z Med J; 2019 Jun; 132(1496):59-65. PubMed ID: 31170134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Lydia Pinkham to Queen Levitra: direct-to-consumer advertising and medicalisation.
    Conrad P; Leiter V
    Sociol Health Illn; 2008 Sep; 30(6):825-38. PubMed ID: 18761506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions of Direct-to-Consumer Advertising and the Older Adult Population.
    Bailey TA; Fenney M
    Consult Pharm; 2016 Apr; 31(4):215-20. PubMed ID: 27056358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A compromise too far: a review of Canadian cases of direct-to-consumer advertising regulation.
    Lexchin J; Mintzes B
    Int J Risk Saf Med; 2014; 26(4):213-25. PubMed ID: 25420763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications.
    Mackey TK; Cuomo RE; Liang BA
    BMC Health Serv Res; 2015 Jun; 15():236. PubMed ID: 26084705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-consumer advertising for erectile dysfunction drugs.
    Karlowicz KA
    Urol Nurs; 2009; 29(4):214. PubMed ID: 19718935
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of DTCA techniques: Appraising their success and potential impact on medication users.
    Babar ZU; Siraj AM; Curley L
    Res Social Adm Pharm; 2018 Mar; 14(3):218-227. PubMed ID: 28434919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From DTCA-PD to patient information to health information: the complex politics and semantics of EU health policy.
    Brooks E; Geyer R
    J Eval Clin Pract; 2012 Dec; 18(6):1235-40. PubMed ID: 22816868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct to consumer advertising in healthcare: history, benefits, and concerns.
    Adeoye S; Bozic KJ
    Clin Orthop Relat Res; 2007 Apr; 457():96-104. PubMed ID: 17310934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease awareness campaigns in printed and online media in Latvia: cross-sectional study on consistency with WHO ethical criteria for medicinal drug promotion and European standards.
    Leonardo Alves T; Poplavska E; Mezinska S; Salmane-Kulikovska I; Andersone L; Mantel-Teeuwisse AK; Mintzes B
    BMC Public Health; 2018 Nov; 18(1):1322. PubMed ID: 30486803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources.
    DeLorme DE; Huh J; Reid LN
    Health Mark Q; 2009; 26(4):293-314. PubMed ID: 19916096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical direct-to-consumer advertising and US Hispanic patient-consumers.
    Barker KK; Vasquez Guzman CE
    Sociol Health Illn; 2015 Nov; 37(8):1337-51. PubMed ID: 26235537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.